Immunovia AB
IMMNOV
Rang in aandelen
#34529
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for... Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Aandeelprijs
$0.00739046
Marktkapitalisatie
$4.97M
Verandering (1 dag)
-3.69%
Verandering (1 jaar)
-78.59%
Land
SE
Handel Immunovia AB (IMMNOV)
Categorie
Healthcare
Koersgeschiedenis voor Immunovia AB (IMMNOV)
Hoogste slotkoers: $0.01 op 2026-10-01
Laagste slotkoers: $12.22 op 2018-01-01
Laagste slotkoers: $12.22 op 2018-01-01
Koersgeschiedenis van Immunovia AB van 2018 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -27.09% |
| 2025 | -57.69% |
| 2024 | -60.72% |
| 2023 | -94.55% |
| 2022 | -61.46% |
| 2021 | -45.87% |
| 2020 | -13.27% |
| 2019 | -8.33% |
| 2018 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $676.48 | 19.27% |
US
|
|
| $229.93 | 5.42% |
US
|
|
| $398.85 | 112.13% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $174.35 | 19.52% |
US
|
